About Integra LifeSciences
Integra LifeSciences is a publicly listed company based in Plainsboro (United States) founded in 1989. Diversified medical devices are developed for healthcare applications. The company has 4,400 employees. Integra LifeSciences has completed 16 acquisitions, including ACell, Acclarent and Arkis BioSciences. Its chief executive, as recorded, is Pete J Arduini. Its website integralife.com draws about 117 thousand monthly visits. Its focus areas include Diversified Medical Devices and Devices. Its legal entity is INTEGRA LIFESCIENCES CORPORATION. Its competitors include GE Healthcare, Medtronic and Boston Scientific; 1 of its 3 listed competitors has raised funding.
Company details
Integra LifeSciences was founded in 1989 and is headquartered in Plainsboro, United States. Operations are centered on the development and distribution of medical devices across multiple specialties, including regenerative technologies and surgical instruments. Products are designed for use in orthopedics, neurosurgery, and wound management. Leadership is provided by CEO and President Pete J. Arduini, with activities spanning research, manufacturing, and global sales in the healthcare sector.
- Headquarters Plainsboro, United States
- Employees 4,400
- Stage Public
- SectorsHealthcare
- Website integralife.com
- Social LinkedIn X
- Legal Name Integra Lifesciences Holdings Corporation
- Annual Revenue$1.64 B (USD)1.53as on Dec 31, 2025
- Net Profit-$516.47 M (USD)-7337.7as on Dec 31, 2025
- EBITDA$334.09 M (USD)3.35as on Dec 31, 2025
- Latest Funding Round$500M (USD), Post-IPO
Feb 2020
- Investors
- Employee Count4,400
- Investments & AcquisitionsACell
& 15 more
Funding Insights of Integra LifeSciences
- Total Rounds 2
- Last Round Post-IPO — $500M
- First Round $2.2B
(May 2018)
- Investors Count 1
All 2 funding rounds of Integra LifeSciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2020 | $500M | Post-IPO | – | – | – |
| May 2018 | $2.2B | Debt – Conventional | – | – |
1 investors in total: 1 institutional.
Investors in Integra LifeSciences
Integra LifeSciences has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Bank of America.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Commercial banking and asset management services are offered worldwide. | 1904 | bankofamerica.com | Charlotte, United States |
Investor details for Integra LifeSciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Integra LifeSciences
610 people are tracked at Integra LifeSciences (163 in leadership, 10 in board & advisors, 437 in team); the tracked headcount is 4,400.
| Name | Role | Group |
|---|---|---|
Pete J Arduini | Chief Executive Officer & President | Leadership |
Jerry Salazar | Vice President Information Technology | Leadership |
Paul Gonsalves | SVP, Chief Commercial Officer | Leadership |
Rajesh P. | Vice President - Information Technology | Leadership |
Madhusudan Vadigicherla | Director, Supply Chain Systems | Leadership |
Nicole Kotter | Director | Leadership |
Sarah Rusin | Senior HR Business Partner | Leadership |
Susan Krause | Corporate VP, Chief Quality Officer | Leadership |
Mojdeh Poul | CEO | Leadership |
Sathiya G Prabaharan | Senior Director, Strategic Initiatives | Leadership |
Laura Rivera | Vice President Of Corporate Financial Planning & Analysis (fp&a) | Leadership |
Dyke Davies | Director, Sales Operations | Leadership |
Yuan Severtson | VP Global Quality Reliability | Leadership |
Matt Ibbett | Head Of Sales | Leadership |
Michelle Hickey | Digital Marketing Director | Leadership |
Raymond Turner | Corporate Vice President & Chief Medical Officer | Leadership |
Angel Enriquez | Director Facilities Engineering | Leadership |
John O'Callaghan | Director, Product Lifecycle Management And Regulatory Systems | Leadership |
Robert T. Davis | EVP & President, Tissue Technologies | Leadership |
Amichai Vardi | VP Quality, Integra Lifesciences | Leadership |
590 more people are available in the full profile.
Complete people profiles for Integra LifeSciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Integra LifeSciences
Integra LifeSciences is a publicly listed company on the NASDAQ with ticker symbol IART in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date16 Aug 1995
- Listed onNASDAQ: IART
- Listed entityIntegra LifeSciences Holdings Corporation
- Exchange sectorHealth technology
- ISINUS4579852082
- Share price$13.85 (-0.93% on the day) · 2026-10-13
- Market capitalisation$1.08B
- EPS (diluted, trailing year)$-0.09
- Volume (last session)818,836
Financials of Integra LifeSciences
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $1.64B | -$516.5M | $334.1M |
| 2024 | $1.61B | -$6.9M | $323.3M |
| 2023 | $1.54B | $67.7M | $344.1M |
| 2022 | $1.56B | $180.6M | $391.1M |
| 2021 | $1.54B | $169.1M | $399.2M |
Detailed financial statements for Integra LifeSciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Integra LifeSciences
Integra LifeSciences has strategically engaged in corporate development activities, having acquired 16 companies. Notable acquisitions include ACell, Acclarent and Arkis BioSciences.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Balloon-based sinuplasty technologies are developed for ENT surgeons. | acclarent.com | Irvine, United States | 2004 | Dec 2023 | $275M | |
Bioabsorbable mesh is developed for reconstructive and aesthetic surgery. | sia.health | Chicago, United States | 2016 | Dec 2022 | •••• | |
Regenerative products for tissue repair are developed using ECM technology. | acell.com | Lafayette, United States | 1999 | Dec 2020 | $300M | |
Imaging devices for minimally invasive surgery are developed. | reboundtx.com | Irvine, United States | 2015 | Sep 2019 | •••• | |
Surgical instrumentation for shunt surgeries | arkisbiosciences.com | Knoxville, United States | 2011 | Jul 2019 | •••• | |
Developer of tissue regeneration and wound care products | dermasciences.com | Princeton, United States | 1984 | Jan 2017 | $200M | |
Biomaterials and devices are developed for tissue repair and regeneration. | teibio.com | Waltham, United States | 1993 | Jun 2015 | •••• | |
Dural repair, surgical sealants, and adhesion barrier products are developed. | confluentsurgical.com | Waltham, United States | 1998 | Oct 2013 | $235M | |
Develops Orthopedic implants focused on upper extremity | ascensionortho.com | Austin, United States | 1996 | Sep 2011 | $65M | |
Spinal disorders are addressed through minimally invasive and motion-preserving technologies. | istspine.com | Plano, United States | 2002 | Sep 2009 | $9.25M |
Complete acquisition details for Integra LifeSciences
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Integra LifeSciences
14 dated milestones of Integra LifeSciences across 34 years, from founding to its latest funding, stage changes and deals.
- Founded Integra LifeSciences is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Innovative Spinal Technologies.
- Acquisition Acquires Ascension Orthopedics.
- Acquisition Acquires Confluent Surgical.
- Acquisition Acquires TEI Biosciences.
- Acquisition Acquires Derma Sciences.
- Funding First funding round of $2.2B.
- Acquisition Acquires Arkis BioSciences.
- Acquisition Acquires Rebound Therapeutics.
- Funding Latest funding round, Post-IPO, of $500.0M.
- Acquisition Acquires ACell.
- Acquisition Acquires SIA Health.
- Acquisition Acquires Acclarent.
Competitors of Integra LifeSciences
Integra LifeSciences has 3 listed competitors in our database, 1 of them funded. They include GE Healthcare, Medtronic and Boston Scientific.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| gehealthcare.com | 1892 | Chicago, United States | $29.13M | 16,700 | Materials management solutions are provided for healthcare organizations. | |
| medtronic.com | 1949 | Minneapolis, United States | 1,114 | Medical equipment for treating over 30 chronic diseases is developed. | ||
| bostonscientific.com | 1979 | Marlborough, United States | 63,359 | Wide range of medical devices |
Detailed competitors of Integra LifeSciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Integra LifeSciences
The website of Integra LifeSciences (integralife.com) receives about 116.5K visits a month.
- Monthly visits116.5K
▲ 30.2% vs previous month
Websites whose visitors overlap most with Integra LifeSciences. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| miltex.com | 100% | View details | |||
hnmmedical.com | hnmmedical.com | 89% | #8,769,214 | – | |
| k2m.com | 88% | View details | |||
| aspensurgical.com | 85% | 39K | #638,928 | View details | |
| nuvasive.com | 84% | 122.8K | #333,205 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Integra LifeSciences
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Diversified Medical Devices
3 companies that operate in the same segment as Integra LifeSciences (Diversified Medical Devices) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medical equipment for treating over 30 chronic diseases is developed. | 1949 | Minneapolis, Minnesota, United States | USD 36.36 B | 95,000 | ||
Wide range of medical devices | 1979 | Marlborough, Massachusetts, United States | USD 20.07 B | 53,000 | ||
Healthcare solutions are provided by Johnson & Johnson globally. | 1886 | New Brunswick, New Jersey, United States | USD 94.18 B | 139,800 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Integra Lifesciences
Complete news archive for Integra LifeSciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Integra LifeSciences
Integra LifeSciences was founded in 1989 and raised its 1st funding round 29 years after it was founded.
Integra LifeSciences is headquartered in Plainsboro, United States. It is registered at Plainsboro, New Jersey, United States.
Pete J Arduini is the CEO of Integra LifeSciences, as recorded in our data.
Integra LifeSciences has 4,400 employees.
Annual revenue of Integra LifeSciences is $1.64B as on Dec 31, 2025.
Integra LifeSciences was founded in 1989 and is headquartered in Plainsboro, United States. Operations are centered on the development and distribution of medical devices across multiple specialties, including regenerative technologies and surgical instruments. Products are designed for use in orthopedics, neurosurgery, and wound management. Leadership is provided by CEO and President Pete J. Arduini, with activities spanning research, manufacturing, and global sales in the healthcare sector.
Integra LifeSciences's top competitors include GE Healthcare, Medtronic and Boston Scientific.
Yes, Integra LifeSciences is publicly traded on NASDAQ under the ticker symbol IART.
Integra LifeSciences has made 16 acquisitions, including ACell, Acclarent, and Arkis BioSciences.
Integra LifeSciences has 1 investor. Key investors include Bank of America.
Integra LifeSciences operates through Integra Lifesciences Corporation.
The website of Integra LifeSciences receives about 117 thousand visits a month.